Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Novartis AG's total inventories for the quarter that ended in Jun. 2026 was MXN108,533 Mil. Novartis AG's average total inventories from the quarter that ended in Mar. 2026 to the quarter that ended in Jun. 2026 was MXN110,943 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Novartis AG's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was MXN-573.43.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Novartis AG's Days Inventory for the
three
months ended in Jun. 2026 was 156.38.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Novartis AG's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.58.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Novartis AG's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.43.
Novartis AG (MEX:NOVNN) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Novartis AG's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Novartis AG's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Novartis AG Total Inventories Related Terms
Novartis AG Total Inventories Historical Data
* Premium members only.
The historical data trend for Novartis AG's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
What does a Total Inventories of MXN108,533 Mil mean?
Novartis AG (MEX:NOVNN) has a Total Inventories of MXN108,533 Mil as of Jun. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Novartis AG and its competitors.
Is Novartis AG's Total Inventories too high?
Novartis AG's current Total Inventories is MXN108,533 Mil. Overall, Novartis AG has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Novartis AG's Total Inventories compare to LLY and JNJ?
Novartis AG's Total Inventories of MXN108,533 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Novartis AG and its competitors. Novartis AG's current Total Inventories is MXN108,533 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis AG stock overvalued right now?
Novartis AG (MEX:NOVNN) has a current Total Inventories of MXN108,533 Mil. The stock's GF Value™ is MXN2,044.52, compared to a current price of MXN2,487.40 — trading 21.7% above its estimated fair value. The current Total Inventories is MXN108,533 Mil. Novartis AG's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Novartis AG (MEX:NOVNN), the current Total Inventories is MXN108,533 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novartis AG (MEX:NOVNN) Overvalued in 2026?
Based on GuruFocus' analysis, Novartis AG stock appears to be overvalued.
The current stock price of MXN2,487.40 is trading 21.7% above its estimated GF Value™ of MXN2,044.52.
Key valuation signals for MEX:NOVNN:
Total Inventories: MXN108,533 Mil
GF Value™: MXN2,044.52 vs. price of MXN2,487.40 (21.7% above fair value)
No single metric tells the full story. See the MEX:NOVNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
80GF Score
Get the complete analysis for MEX:NOVNN
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NOVNN has been successfully added to your 
